352 related articles for article (PubMed ID: 8934362)
1. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
Li JS; Sventek P; Schiffrin EL
J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
[TBL] [Abstract][Full Text] [Related]
2. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
[TBL] [Abstract][Full Text] [Related]
4. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelin-1 gene expression and effect on blood pressure of chronic ETA endothelin receptor antagonism after nitric oxide synthase inhibition with L-NAME in normal rats.
Sventek P; Turgeon A; Schiffrin EL
Circulation; 1997 Jan; 95(1):240-4. PubMed ID: 8994442
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension.
Li L; Fink GD; Watts SW; Northcott CA; Galligan JJ; Pagano PJ; Chen AF
Circulation; 2003 Feb; 107(7):1053-8. PubMed ID: 12600921
[TBL] [Abstract][Full Text] [Related]
10. Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats.
Li JS; Schiffrin EL
J Cardiovasc Pharmacol; 1996 Jul; 28(1):68-74. PubMed ID: 8797138
[TBL] [Abstract][Full Text] [Related]
11. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
[TBL] [Abstract][Full Text] [Related]
12. Effect of vasopressin antagonism on structure and mechanics of small arteries and vascular expression of endothelin-1 in deoxycorticosterone acetate salt hypertensive rats.
Intengan HD; He G; Schiffrin EL
Hypertension; 1998 Oct; 32(4):770-7. PubMed ID: 9774378
[TBL] [Abstract][Full Text] [Related]
13. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
Karam H; Clozel JP; Bruneval P; Gonzalez MF; Ménard J
Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345
[TBL] [Abstract][Full Text] [Related]
14. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats.
Pu Q; Touyz RM; Schiffrin EL
J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
Schiffrin EL; Larivière R; Li JS; Sventek P
J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
[TBL] [Abstract][Full Text] [Related]
16. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Li JS; Larivière R; Schiffrin EL
Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
[TBL] [Abstract][Full Text] [Related]
17. Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1.
Edwards DL; Arora CP; Bui DT; Castro LC
Am J Obstet Gynecol; 1996 Aug; 175(2):484-8. PubMed ID: 8765273
[TBL] [Abstract][Full Text] [Related]
18. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
Li JS; Schürch W; Schiffrin EL
Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
[TBL] [Abstract][Full Text] [Related]
19. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
[TBL] [Abstract][Full Text] [Related]
20. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
